|
What do the evidence and interaction scores represent in the molecular interactions evidence file?
|
|
1
|
106
|
23 September 2022
|
|
Data statistics of Open Targets
|
|
2
|
201
|
13 September 2022
|
|
How is the V2G score calculated?
|
|
5
|
269
|
17 August 2022
|
|
Which FAERS pharmacovigilance data release is used in the Open Targets Platform?
|
|
1
|
138
|
17 August 2022
|
|
Indirect data included in the direct associations data
|
|
1
|
118
|
15 August 2022
|
|
Is it possible to get all possibly causal variants from a GWAS through OpenTargets Genetics?
|
|
2
|
145
|
24 July 2022
|
|
Questions about the 22.06 dataset — overlap in disease terms/multiple entries for disease-gene associations
|
|
3
|
185
|
9 July 2022
|
|
What is the significance threshold of PheWAS plots?
|
|
3
|
302
|
7 July 2022
|
|
Enrichment analysis for a list of Protein
|
|
2
|
160
|
1 July 2022
|
|
Is it possible to convert Gene Symbol to Ensembl ID?
|
|
4
|
645
|
28 June 2022
|
|
Searching for associations with a set of diseases and phenotypes (and how to find that set)
|
|
1
|
196
|
10 June 2022
|
|
How to get ontology data for Open Targets Genetics?
|
|
1
|
144
|
10 June 2022
|
|
How to group associations by therapeutic area?
|
|
8
|
206
|
6 June 2022
|
|
Question and solved status
|
|
1
|
108
|
18 May 2022
|
|
Is it possible to identify gene fusions signatures related to a given disease?
|
|
2
|
254
|
8 February 2022
|
|
What is ebisearchEvidence/Association?
|
|
1
|
200
|
14 December 2021
|
|
Differences between associations in the UI and associations in the data downloads (21.04)
|
|
6
|
402
|
28 July 2021
|
|
How to interpret colocalisation analyses, lead and tag variants in the Open Targets Genetics Portal
|
|
0
|
212
|
17 June 2021
|
|
Mismatch between maximum clinical trial phase and phases by indication?
|
|
2
|
256
|
11 May 2021
|
|
Welcome message
|
|
2
|
228
|
29 April 2021
|